Comprehensive analysis of the characteristics and treatment outcomes of patients with non-small cell lung cancer treated with anti-PD-1 therapy in real-world practice

PURPOSE: Immune checkpoint inhibitors (ICI) have shown marked responses in patients with non-small cell lung cancer (NSCLC) in clinical trials. However, because such trials comprise cohorts selected based on specific criteria, it is unclear if their results represent routine clinical practice. METHO...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cancer Res Clin Oncol
Main Authors: Ahn, Beung-Chul, Pyo, Kyoung-Ho, Xin, Chun-Feng, Jung, Dongmin, Shim, Hyo Sup, Lee, Chang Young, Park, Seong Yong, Yoon, Hong In, Hong, Min Hee, Cho, Byoung Chul, Kim, Hye Ryun
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2019
Assuntos:
Original Article – Clinical Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6527531/
https://ncbi.nlm.nih.gov/pubmed/30911841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00432-019-02899-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados